+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Exosome Diagnostics and Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product; Service; Application; & End User

  • ID: 5023739
  • Report
  • April 2020
  • Region: Global
  • 149 pages
  • The Insight Partners
1 of 3

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Aethlon Medical, Inc
  • BioRegenerative Sciences
  • Cell Guidance Systems LLC
  • Evomic Science LLC
  • Miltenyi Biotech
  • Norgen Biotek Corp
  • MORE
The exosome diagnostic and therapeutic market was valued at US$ 41.63 million in 2019 and is expected to grow at a CAGR of 32.2% from 2020 to 2027 to reach US$ 358.91 million by 2027.

Driving factors of the exosome diagnostic and therapeutic market are greater precision and advantages over traditional methods of diagnosis and therapeutics and increasing number of research activities in the field of exosomes. However, poor infrastructure and lack of expertise required for isolation of exosomes are expected to restrain the growth of the market during the forecast period.

Exosomes are distinct populations of tiny membranous vesicles, released into the extracellular space by most cells, which get eventually accumulated in the body fluid circulation. By acting as cellular messengers, they play a role in vital physiological functions by transporting information between different cell types. Several healthcare organizations and industry players are implementing constructive strategies to boost the research and development pertaining to exosome applications. For instance, in October 2019, the American Type Culture Collection (ATCC), a premier global biological materials and information resource and standards organization, launched a new range of human-derived cell-specific exosomes to serve as reference materials for boosting drug and diagnostics development activities.

The global exosome diagnostic and therapeutics segmented by application, product, and end user. The exosome diagnostic and therapeutic market, by application, is further segmented into diagnostic applications and therapeutic applications. The diagnostic segment held a larger share of the market in 2019. Also, the diagnostic segment is anticipated to register a higher CAGR in the market during the forecast period. Based on product, the market is sub segmented into instruments, reagents, and software. The instruments segment held the largest share of the market in 2019, whereas the software segment is estimated to register the highest CAGR in the market during the forecast period. Based on end user, the exosome diagnostic and therapeutic market is further segmented into cancer institute, hospitals, diagnostic centers, and others. The cancer institute segment held the largest share of the market in 2019and is also projected to register the fastest growth.

A few essential primary and secondary sources included in the report are European Medical Association, Center for Drug Evaluation and Research and European Federation of Pharmaceuticals Industries Associations.

Reasons to Buy
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the exosome diagnostic and therapeutic market.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global exosome diagnostic and therapeutic market, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Aethlon Medical, Inc
  • BioRegenerative Sciences
  • Cell Guidance Systems LLC
  • Evomic Science LLC
  • Miltenyi Biotech
  • Norgen Biotek Corp
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Report Guidance
1.3 Market Segmentation
1.3.1 Global Exosome diagnostic and therapeutic Market - By Application
1.3.2 Global Exosome diagnostic and therapeutic Market - By Product
1.3.3 Global Exosome diagnostic and therapeutic Market - By End User
1.3.4 Global Exosome Diagnostic and Therapeutic Market - By Geography

2. Exosome Diagnostic And Therapeutic Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Global Exosome Diagnostic and Therapeutic Market - Market Landscape
4.1 Overview
4.2 Pest Analysis
4.2.1 North America - PEST Analysis
4.2.2 Europe- PEST Analysis
4.2.3 Asia Pacific- PEST Analysis
4.2.4 Middle East & Africa- PEST Analysis
4.2.5 South and Central America - PEST Analysis

5. Global Exosome Diagnostic and Therapeutic Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Greater Precision and Advantages over Traditional Methods of Diagnosis and Therapeutics
5.1.2 Rise in Research and Development Activities
5.2 Key Market Restraints
5.2.1 Poor Infrastructure and Lack of Expertise Required for Isolation of Exosomes
5.3 Key Market Opportunities
5.3.1 Growing Preference for Non-invasive and Novel Diagnostic Procedures
5.4 Future Trends
5.4.1 Automation of Exosome Isolation Process
5.5 Impact analysis

6. Exosome Diagnostic and Therapeutic Market- Global Analysis
6.1 Global Exosome Diagnostic and Therapeutic Market Revenue Forecast And Analysis
6.2 Global Exosome Diagnostic and Therapeutic Market, By Geography - Forecast And Analysis
6.3 Market Positioning of Key Players

7. Exosome Diagnostic and Therapeutic Market Analysis - By Application
7.1 Overview
7.2 Exosome Diagnostic and Therapeutic Market Share, by Application, 2019 and 2027 (%)
7.3 Diagnostic
7.3.1 Overview
7.3.2 Diagnostic: Exosome Diagnostic and Therapeutic Market- Revenue and Forecast to 2027 (US$ Thousand)
7.4 Therapeutic
7.4.1 Overview
7.4.2 Therapeutic: Exosome Diagnostic and Therapeutic Market- Revenue and Forecast to 2027 (US$ Thousand)

8. Exosome Diagnostic and Therapeutic Market Analysis - By Product
8.1 Overview
8.2 Exosome Diagnostic and Therapeutic Market Share, by Product, 2019 and 2027, (%)
8.3 Instruments
8.3.1 Overview
8.3.2 Instruments: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
8.4 Reagents
8.4.1 Overview
8.4.2 Reagents: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
8.5 Software
8.5.1 Overview
8.5.2 Software: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)

9. Exosome Diagnostic and Therapeutic Market Analysis - By End User
9.1 Overview
9.2 Exosome Diagnostic and Therapeutic Market Share, by End User, 2019 and 2027, (%)
9.3 Cancer Institutes
9.3.1 Overview
9.3.2 Cancer Institutes: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
9.4 Hospitals
9.4.1 Overview
9.4.2 Hospitals: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
9.5 Diagnostic Centres
9.5.1 Overview
9.5.2 Diagnostic Centres: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
9.6 Other End User
9.6.1 Overview
9.6.2 Other End Users: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)

10. Exosome Diagnostic and Therapeutic Market - Geographic Analysis
10.1 North America: Exosome Diagnostic and Therapeutic Market
10.1.1 Overview
10.1.2 North America: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.1.3 North America: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousands)
10.1.4 North America: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.1.5 North America: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.1.6 North America: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
10.1.7 US: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.1.7.1 US: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.1.7.2 US: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.1.7.3 US: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.1.7.4 US: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.1.8 Canada: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.1.8.1 Canada: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.1.8.2 Canada: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.1.8.3 Canada: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.1.8.4 Canada: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.1.9 Mexico: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.1.9.1 Mexico: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.1.9.2 Mexico: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.1.9.3 Mexico: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.1.9.4 Mexico: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.2 Europe: Exosome Diagnostic and Therapeutic Market
10.2.1 Overview
10.2.2 Europe: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.2.3 Europe: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousands)
10.2.4 Europe: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.2.5 Europe: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.2.6 Europe: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
10.2.7 Germany: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.2.7.1 Germany: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.2.7.2 Germany: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.2.7.3 Germany: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.2.7.4 Germany: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.2.8 France: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.2.8.1 France: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.2.8.2 France: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.2.8.3 France: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.2.8.4 France: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.2.9 UK: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.2.9.1 UK: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.2.9.2 UK: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.2.9.3 UK: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.2.9.4 UK: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.2.10 Italy: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.2.10.1 Italy: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.2.10.2 Italy: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.2.10.3 Italy: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.2.10.4 Italy: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.2.11 Spain: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.2.11.1 Spain: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.2.11.2 Spain: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.2.11.3 Spain: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.2.11.4 Spain: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.3 Asia Pacific: Exosome Diagnostic and Therapeutic Market
10.3.1 Overview
10.3.2 Asia Pacific: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.3.3 Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousands)
10.3.4 Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.3.5 Asia Pacific: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.3.6 Asia Pacific: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
10.3.7 China: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.3.7.1 China: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.3.7.2 China: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.3.7.3 China: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.3.7.4 China: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.3.8 Japan: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.3.8.1 Japan: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.3.8.2 Japan: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.3.8.3 Japan: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.3.8.4 Japan: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.3.9 India: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.3.9.1 India: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.3.9.2 India: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.3.9.3 India: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.3.9.4 India: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.3.10 South Korea: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.3.10.1 South Korea: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.3.10.2 South Korea: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.3.10.3 South Korea: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.3.10.4 South Korea: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.3.11 Australia: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.3.11.1 Australia: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.3.11.2 Australia: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.3.11.3 Australia: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.3.11.4 Australia: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.4 Middle East and Africa: Exosome Diagnostic and Therapeutic Market
10.4.1 Overview
10.4.2 Middle East and Africa: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.4.3 Middle East and Africa: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousands)
10.4.4 Middle East and Africa: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.4.5 Middle East and Africa: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.4.6 Middle East and Africa: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
10.4.7 UAE: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.4.7.1 UAE: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.4.7.2 UAE: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.4.7.3 UAE: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.4.7.4 UAE: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.4.8 Saudi Arabia: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.4.8.1 Saudi Arabia: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.4.8.2 Saudi Arabia: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.4.8.3 Saudi Arabia: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.4.8.4 Saudi Arabia: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.4.9 South Africa: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.4.9.1 South Africa: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.4.9.2 South Africa: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.4.9.3 South Africa: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.4.9.4 South Africa: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.5 South and Central America: Exosome Diagnostic and Therapeutic Market
10.5.1 Overview
10.5.2 South and Central America: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (US$ Thousand)
10.5.3 South and Central America: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.5.4 South and Central America: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.5.5 South and Central America: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.5.6 South and Central America: Exosome Diagnostic and Therapeutic Market, by Country, 2019& 2027 (%)
10.5.7 Brazil: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.5.7.1 Brazil: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.5.7.2 Brazil: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.5.7.3 Brazil: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.5.7.4 Brazil: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)
10.5.8 Argentina: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.5.8.1 Argentina: Exosome Diagnostic and Therapeutic Market - Revenue and Forecast to 2027 (USD Thousand)
10.5.8.2 Argentina: Exosome Diagnostic and Therapeutic Market, by Application, 2018-2027 (USD Thousand)
10.5.8.3 Argentina: Exosome Diagnostic and Therapeutic Market, by Product, 2018-2027 (USD Thousand)
10.5.8.4 Argentina: Exosome Diagnostic and Therapeutic Market, by End User, 2018-2027 (USD Thousand)

11. Impact Of COVID-19 Pandemic On Global Exosome Diagnostic And Therapeutic Market
11.1 North America: Impact assessment of COVID-19 Pandemic
11.2 Europe: Impact assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact assessment of COVID-19 Pandemic
11.4 Rest of World: Impact assessment of COVID-19 Pandemic

12. Exosome Diagnostic and Treatment Market -Industry Landscape
12.1 Overview
12.2 Growth Strategies In The Exosome diagnostic and treatment Market, 2017-2020
12.3 Inorganic Growth Strategies
12.3.1 Overview
12.4 Organic Growth Strategies
12.4.1 Overview

13. Company Profiles
13.1 Cell Guidance Systems
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Bioregenerative Sciences
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Evomic Science LLC
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Norgen Biotek Corp
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Miltenyi Biotec
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Therapeutic Solutions International, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 SWOT Analysis
13.6.5 Key Developments
13.7 Aethlon Medical, Inc
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 RENEURON GROUP PLC
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 ITH, Immune Therapy Holdings AB
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Exosome Diagnostics
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments

14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
  • Aethlon Medical, Inc
  • Therapeutic Solutions International, Inc
  • ReNeuron Group plc
  • Immune Therapy Holdings AB
  • Cell Guidance Systems LLC
  • BioRegenerative Sciences
  • Evomic Science LLC
  • Norgen Biotek Corp
  • Exosome Diagnostics, Inc./Bio-Techne
  • Miltenyi Biotech
Note: Product cover images may vary from those shown
Adroll
adroll